Rozlytrek (entrectinib)

pCPA File Number: 21461

Negotiation Status:

Concluded with an LOI

Indication(s):

ROS1-positive Non-Small Cell Lung Cancer

Sponsor/Manufacturer:

Hoffmann-La Roche Ltd.

CDA-AMC Project Number:

PC0206-000

pCPA Engagement Letter Issued:

2021-05-04

Negotiation Process Concluded:

2021-07-06